Ordinary Index Rebalancing in the Solactive Future Pharmaceutical Europe Index | September 2019

In the ordinary rebalance the following composition will be implemented:

ASTRAZENECA PLC
BAYER AG
GLAXOSMITHKLINE PLC
GRIFOLS SA CLASS A
H LUNDBECK AS
HIKMA PHARMACEUTICALS PLC
IPSEN SA
MERCK KGAA
NOVARTIS AG
NOVO NORDISK AS CLASS B
RECORDATI SPA
ROCHE HOLDING AG
SANOFI SA
UCB SA
VIFOR PHARMA AG